Concepedia

Ken R. Bundell

KR

3

Publications

418

Citations

3

H-Index

1993

Active since

Affiliations

AstraZeneca (United Kingdom)(Current)

Ken R. Bundell is an author at AstraZeneca (United Kingdom) specializing in medicine, signal transduction, and cell biology.

Top concepts

Publications per year

1993–2005

3

Publications

3

Characterisation of cell‐penetrating peptide‐mediated peptide delivery

Simon W. Jones, Richard Christison, Ken R. Bundell et al. · British Journal of Pharmacology · 2005 · 385 citations · Full text

, , +20

Pharmacological characterization of cloned human NK-2 (neurokinin A) receptor expressed in a baculovirus/Sf-21 insect cell system.

David Aharony, J Little, Stephen Joseph Powell et al. · Molecular Pharmacology · 1993 · 17 citations

A dominant negative form of IKK2 prevents suppression of apoptosis by the peroxisome proliferator nafenopin

Sabina Cosulich, Neil H. James, M. Needham et al. · Carcinogenesis · 2000 · 16 citations · Full text

, , +22

Rows per page

1–3 of 3